Quantitative molecular evaluation of minimal residual disease in patients with chronic lymphocytic leukemia: efficacy of in vivo purging by alemtuzumab (Campath-1H).
| Image |  |
|---|---|
| Description | scientific article published on September 2004 |
| Author/s |
author: Francesco Caracciolo |
| Publication date | September 1, 2004 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |